z-logo
open-access-imgOpen Access
Formulation and Development of Fast Disintegrating Azelnidipine Tablets: Functionality of Superdisintegrants
Author(s) -
S.K. Sathish,
V.P. Pandey
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v68i02.017
Subject(s) - friability , dissolution , solubility , chemistry , materials science , factorial experiment , chromatography , nuclear chemistry , drug , pharmacology , mathematics , first pass effect , medicine , organic chemistry , statistics
Azelnidipine, a calcium channel blocker, is used for hypertension and angina pectoris. Azelnidipine fast-disintegrating tablets (FDT)have been prepared by kneading method. In the present study cyclodextrins (?CD and HP?CD) and surfactants (Kolliphor HS15) were tried to enhance the solubility and dissolution rate of Azelnidipine. The individual main effects and combined (interaction) effects of cyclodextrins and surfactants on the solubility and dissolution rate of Azelnidipine was evaluated in a series of 22 factorial experiments.) The hardness, friability, drug content and disintegration time, in vitro release and stability parameter has been studied. Hardness of the tablets was in the range 6.0 –7.5 kg/sq.cm. Percent weight loss in the friability test was less than 0.85% with all the formulations. The disintegration time was in the range 1 –3.5 min. with all the tablets prepared. Drug content of the tablets was within 100 ± 2% of the labeled claim. The dissolution efficiency was also increased from 4.56% for formulation E1 to 41.54 % and 36.59 % respectively for formulations E4 and E8. The formulation did not show any change in disintegration time and drug content after stability period. It was concluded that fast disintegrating Azelnidipine tablets can be prepared by kneading method using super disintegrants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here